Skip to main content
. 2021 Dec 20;144(5):050801. doi: 10.1115/1.4053086

Table 1.

Summary of the impact of enzymatic GAG degradation and decorin and/or biglycan mouse knockout (K/O) on tendon quasi-static and viscoelastic material properties during fiber direction tension

Publication Tissue Treatment Impact on quasi-static mechanics Impact on viscoelastic mechanics
Lujan et al., 2007 [70] Human MCL Chondroitinase B -- Peak stress, linear modulus -- Hysteresis
Fessel and Snedeker, 2009 [25] Rat tail tendon fascicles Chondroitinase ABC N/A -- Storage modulus, loss modulus
Lujan et al., 2009 [71] Human MCL Chondroitinase ABC N/A -- Stress relaxation, dynamic modulus, phase shift, peak stress
Rigozzi et al., 2009 [72] Murine Achilles tendon Chondroitinase ABC -- Ultimate stress, linear modulus, failure stress N/A
Svensson et al., 2011 [26] Human patellar tendon Chondroitinase ABC -- Linear modulus, peak stress, peak strain -- Hysteresis
Legerlotz et al., 2013 [73] Bovine extensor tendon fascicles Chondroitinase ABC -- Failure stress, failure strain, linear modulus ↑ Stress relaxation (after 300 s)
Robinson et al., 2004 [74] Murine tendon tail fascicles Decorin K/O -- Peak stress, linear modulus ↓ Strain rate sensitivity
Zhang et al., 2006 [75] Murine FDL tendon Decorin K/O -- Peak stress, linear modulus N/A
Dourte et al., 2012 [76] Murine patellar tendon Decorin K/O -- Toe modulus, linear modulus -- Phase shift
Connizzo et al., 2013 [77] Murine SST Decorin K/O -- Linear modulus -- Stress relaxation
Biglycan K/O -- Linear modulus -- Stress relaxation
Dourte et al., 2013 [78] Murine patellar tendon Biglycan K/O -- Toe modulus, linear modulus -- Stress relaxation
↓ Failure stress ↑ Dynamic modulus
Robinson et al., 2017 [79] Murine patellar tendon Decorin and biglycan K/O -- Linear modulus ↑ Stress relaxation, phase shift

(--) Indicates that there were no significant differences in the listed properties between control and treatment groups, (↑) indicates that the listed properties were significantly increased in the treatment group compared to the control group, and (↓) indicates that the listed properties were significantly decreased in the treatment group compared to the control group.

HHS Vulnerability Disclosure